ATE376066T1 - Verfahren zur abschätzung der sensitivität für osteoporose-medikamente - Google Patents

Verfahren zur abschätzung der sensitivität für osteoporose-medikamente

Info

Publication number
ATE376066T1
ATE376066T1 AT00110219T AT00110219T ATE376066T1 AT E376066 T1 ATE376066 T1 AT E376066T1 AT 00110219 T AT00110219 T AT 00110219T AT 00110219 T AT00110219 T AT 00110219T AT E376066 T1 ATE376066 T1 AT E376066T1
Authority
AT
Austria
Prior art keywords
genetic polymorphisms
osteoporosis
receptor gene
gene
medicine
Prior art date
Application number
AT00110219T
Other languages
English (en)
Inventor
Masataka Shiraki
Yasuyoshi Ouchi
Takayuki Hosoi
Nobutaka Kusaba
Toshiaki Baba
Hiroshi Yoshida
Original Assignee
Nipro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP16564299A external-priority patent/JP3684921B2/ja
Application filed by Nipro Corp filed Critical Nipro Corp
Application granted granted Critical
Publication of ATE376066T1 publication Critical patent/ATE376066T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AT00110219T 1999-05-18 2000-05-18 Verfahren zur abschätzung der sensitivität für osteoporose-medikamente ATE376066T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13665399 1999-05-18
JP16564299A JP3684921B2 (ja) 1999-06-11 1999-06-11 骨粗鬆症薬剤感受性予測方法

Publications (1)

Publication Number Publication Date
ATE376066T1 true ATE376066T1 (de) 2007-11-15

Family

ID=26470156

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00110219T ATE376066T1 (de) 1999-05-18 2000-05-18 Verfahren zur abschätzung der sensitivität für osteoporose-medikamente

Country Status (4)

Country Link
US (1) US6566064B1 (de)
EP (1) EP1054066B1 (de)
AT (1) ATE376066T1 (de)
DE (1) DE60036750T2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005500246A (ja) * 2001-12-03 2005-01-06 マギル ユニヴァーシティー メチレンテトラヒドロ葉酸還元酵素阻害剤およびそれらの使用
KR100459493B1 (ko) * 2002-01-31 2004-12-03 김기수 골다공증의 발생 위험을 예측하는 방법 및 이를 이용한골다공증의 유전적 위험 인자에 대한 진단 키트
US8688385B2 (en) 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
AU2005247948A1 (en) * 2004-05-27 2005-12-08 Migenix Corp. 2-substituted 17-imino estrogen compounds for cytoprotection
WO2006091092A1 (en) * 2005-02-28 2006-08-31 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Polymorphism analysis of the estrogen receptor and vitamin d receptor to predict therapy responsiveness in the treatment of osteoporosis
WO2007064675A2 (en) * 2005-11-29 2007-06-07 Children's Hospital Medical Center Optimization and individualization of medication selection and dosing
GB0614620D0 (en) * 2006-07-24 2006-08-30 Genomica Sau Assay for diagnosing a predisposition to pathological bone conditions and anticipating response to treatment
WO2011031601A2 (en) 2009-09-14 2011-03-17 Nestec S.A. Nutritional compositions including exogenous vitamin k2
US10853819B2 (en) 2011-04-14 2020-12-01 Elwha Llc Cost-effective resource apportionment technologies suitable for facilitating therapies
US10445846B2 (en) 2011-04-14 2019-10-15 Elwha Llc Cost-effective resource apportionment technologies suitable for facilitating therapies
CN108451929B (zh) * 2017-02-21 2021-04-16 上海交通大学医学院 一种包载固相内核的重组脂蛋白及其制备和应用

Also Published As

Publication number Publication date
DE60036750D1 (de) 2007-11-29
EP1054066A3 (de) 2004-02-25
DE60036750T2 (de) 2008-08-28
EP1054066B1 (de) 2007-10-17
US6566064B1 (en) 2003-05-20
EP1054066A2 (de) 2000-11-22

Similar Documents

Publication Publication Date Title
CN105112502B (zh) 用于检测与糖尿病相关的snp位点组合的成套引物及其应用
ATE376066T1 (de) Verfahren zur abschätzung der sensitivität für osteoporose-medikamente
CN107190064B (zh) 检测22个位点耳聋基因多态性的SNaPshot试剂盒
US20150299796A1 (en) Prediction of treatment response to jak/stat inhibitor
CN104818316B (zh) 用于筛查柳氮磺胺吡啶所致皮肤药物不良反应的人类白细胞抗原基因检测试剂盒
Pehlivan et al. The role of combined SNV and CNV burden in patients with distal symmetric polyneuropathy
CN106987642A (zh) 检测mpl基因全外显子的试剂盒和方法
CN103114138B (zh) Pcr-ssp法定性检测hla-b*1502基因的方法及临床试剂盒
JP5216982B2 (ja) 禁煙支援治療に有用な遺伝子多型
EP3588508A1 (de) Analyseverfahren, informationsverarbeitungsvorrichtung und nichttransitorisches computerlesbares medium
JP2017503493A5 (de)
CN110656112B (zh) 一种Liddle综合征基因检测试剂盒
KR101712463B1 (ko) 혈압강하제 및 동맥 경화용제 대사효소 관련 유전자 snp 지노타이핑 시약, 이를 포함하는 키트 및 유전자형 분석방법
DE60014887D1 (de) Analyseverfahren zur feststellung der prädisposition enes patienten auf mindestens eine erkrankung sowie geeignete amplifizierung für ein solches verfahren
JP6596724B1 (ja) 白髪の遺伝的素因の判定方法
EP3627513A1 (de) Analyseverfahren, informationsverarbeitungsvorrichtung, genanalysesystem und nichttransitorisches speichermedium
Chiou et al. Detection of common sequence variations of familial hypercholesterolemia in Taiwan using DNA mass spectrometry
Garcia et al. Haplotype analysis of the first A4V-SOD1 Spanish family: two separate founders or a single common founder?
JPWO2020138435A1 (ja) 眼内悪性リンパ腫の補助的診断法
RU2006101561A (ru) Способы обнаружения болезни альцгеймера
CN114729395A (zh) 检查脑肿瘤的方法
EP4600373A1 (de) Datensammelverfahren und kit zur bestimmung der wahrscheinlichkeit der entwicklung von morbus alzheimer
CN107828889B (zh) 一种用于hla-drb1*03基因定性检测的pcr扩增引物及试剂盒
JP5396009B2 (ja) 骨粗鬆症感受性遺伝子、及び骨粗鬆症罹患リスクの測定方法
KR101046344B1 (ko) Ｓｎｔｇ２의 다형성 및 이의 일배체를 바이오마커로 이용한 뇌졸중 진단방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties